dasatinib (SPRYCEL)

DRUG2 trials

Sponsors

University of Pittsburgh, European Society for Blood and Marrow Transplantation

Conditions

Acute Myelogenous LeukemiaChronic Myeloid LeukemiaMyelodysplastic Syndrome

Phase 1

Study of Dasatinib and All-Trans Retinoic Acid for Relapsed/Refractory and/or Elderly Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome

CompletedNCT00892190

University of PittsburghAcute Myelogenous Leukemia, Myelodysplastic Syndrome

Start: 2011-04-30End: 2016-02-29Updated: 2016-02-10

Phase 2

Efficacy and Safety Study of Dasatinib in Patients With Chronic Myeloid Leukemia

TerminatedNCT00895297

European Society for Blood and Marrow TransplantationChronic Myeloid Leukemia

Start: 2010-02-28End: 2011-11-30Target: 50Updated: 2011-12-07